Concepedia

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

Dong I. Lee, Guangshuo Zhu, Takashi Sasaki, Gun-Sik Cho, Nazha Hamdani, Ronald J. Holewinski, Su‐Hyun Jo, Thomas Danner, Manling Zhang, Peter P. Rainer,

Nature · 2015 · 349 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text

, , +11

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

Margaret M. Redfield, Horng H. Chen, Barry A. Borlaug et al. · JAMA · 2013 · 1.1K citations

, , +13

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart

Bin Zhou, Qing Ma, Satish Rajagopal et al. · Nature · 2008 · 1K citations · Full text

, , +13

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

Eiki Takimoto, Hunter C. Champion, Manxiang Li et al. · Nature Medicine · 2005 · 898 citations

, , +13

Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

Loek van Heerebeek, Nazha Hamdani, Inês Falcão‐Pires et al. · Circulation · 2012 · 503 citations · Full text

, , +13